Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15901)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 14, 2017 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kostrzewski T, Cornforth T, Snow SA, Ouro-Gnao L, Rowe C, Large EM, Hughes DJ. Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease. World J Gastroenterol 2017; 23(2): 204-215 [PMID: 28127194 DOI: 10.3748/wjg.v23.i2.204] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v23/i2/204.htm |
| Number | Citing Articles |
| 1 |
Franck Da-silva, Xavier Boulenc, Hélène Vermet, Pauline Compigne, Sabine Gerbal-Chaloin, Martine Daujat-Chavanieu, Sylvie Klieber, Patrick Poulin. Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin Binding. Journal of Pharmaceutical Sciences 2018; 107(7): 1957 doi: 10.1016/j.xphs.2018.03.001
|
| 2 |
Abdul M. Oseini, Banumathi K. Cole, Danny Issa, Ryan E. Feaver, Arun J. Sanyal. Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitis. Hepatology International 2018; 12(1): 6 doi: 10.1007/s12072-017-9838-6
|
| 3 |
Aylin Acun, Letao Fan, Ruben Oganesyan, Korkut M. Uygun, Heidi Yeh, Martin L. Yarmush, Basak E. Uygun. Effect of Donor Age and Liver Steatosis on Potential of Decellularized Liver Matrices to be used as a Platform for iPSC‐Hepatocyte Culture. Advanced Healthcare Materials 2024; doi: 10.1002/adhm.202302943
|
| 4 |
Banumathi K. Cole, Ryan E. Feaver, Brian R. Wamhoff, Ajit Dash. Non-alcoholic fatty liver disease (NAFLD) models in drug discovery. Expert Opinion on Drug Discovery 2018; 13(2): 193 doi: 10.1080/17460441.2018.1410135
|
| 5 |
Shi-Xiang Wang, Ji-Song Yan, Yun-Shen Chan. Advancements in MAFLD Modeling with Human Cell and Organoid Models. International Journal of Molecular Sciences 2022; 23(19): 11850 doi: 10.3390/ijms231911850
|
| 6 |
David J Hughes, Tomasz Kostrzewski, Emma L Sceats. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems. Experimental Biology and Medicine 2017; 242(16): 1593 doi: 10.1177/1535370217708976
|
| 7 |
Yasamin A. Jodat , Min G. Kang, Kiavash Kiaee, Gyeong J. Kim, Angel F.H. Martinez, Aliza Rosenkranz, Hojae Bae , Su R. Shin. Human-Derived Organ-on-a-Chip for Personalized Drug Development. Current Pharmaceutical Design 2019; 24(45): 5471 doi: 10.2174/1381612825666190308150055
|
| 8 |
Francois Taute, Antoni Homs-Corbera, Pierre Gaudriault. The challenges and considerations for emerging or future entrepreneurial researchers in microphysiological systems. Open Research Europe 2021; 1: 38 doi: 10.12688/openreseurope.13335.1
|
| 9 |
Nathalie K. Zgheib, Juan J.L. Lertora, Robert A. Branch. Atkinson's Principles of Clinical Pharmacology. 2022; : 91 doi: 10.1016/B978-0-12-819869-8.00005-7
|
| 10 |
Tim Brecklinghaus, Wiebke Albrecht, Julia Duda, Franziska Kappenberg, Lisa Gründler, Karolina Edlund, Rosemarie Marchan, Ahmed Ghallab, Cristina Cadenas, Adrian Rieck, Nachiket Vartak, Laia Tolosa, José V. Castell, Iain Gardner, Emina Halilbasic, Michael Trauner, Anett Ullrich, Anja Zeigerer, Özlem Demirci Turgunbayer, Georg Damm, Daniel Seehofer, Jörg Rahnenführer, Jan G. Hengstler. In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay. Toxicology Letters 2022; 368: 33 doi: 10.1016/j.toxlet.2022.08.006
|
| 11 |
Nithin R, Ayushi Aggarwal, Anne Boyina Sravani, Pooja Mallya, Shaila Lewis. Organ-On-A-Chip: An Emerging Research Platform. Organogenesis 2023; 19(1) doi: 10.1080/15476278.2023.2278236
|
| 12 |
Christoph Grün, Brigitte Altmann, Eric Gottwald. Advanced 3D Cell Culture Techniques in Micro-Bioreactors, Part I: A Systematic Analysis of the Literature Published between 2000 and 2020. Processes 2020; 8(12): 1656 doi: 10.3390/pr8121656
|
| 13 |
Alexandre J. S. Ribeiro, Xinning Yang, Vikram Patel, Rajnikanth Madabushi, David G. Strauss. Liver Microphysiological Systems for Predicting and Evaluating Drug Effects. Clinical Pharmacology & Therapeutics 2019; 106(1): 139 doi: 10.1002/cpt.1458
|
| 14 |
Andreas R. Baudy, Monicah A. Otieno, Philip Hewitt, Jinping Gan, Adrian Roth, Douglas Keller, Radhakrishna Sura, Terry R. Van Vleet, William R. Proctor. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry. Lab on a Chip 2020; 20(2): 215 doi: 10.1039/C9LC00768G
|
| 15 |
Bhumika Singh, Mohamed Essameldin Abdelgawad, Zulfiqur Ali, Jarrod Bailey, Elisa Budyn, Prospero Civita, Martin J.D. Clift, John T. Connelly, Samuel Constant, Marius Hittinger, Helena Kandarova, Victoria Rosalind Kearns, Tony Kiuru, Tomasz Kostrzewski, Sebastian Kress, Victoria Marsh Durban, Claus-Michael Lehr, Hayley McMillan, Julia Katharina Metz, Vivian Monteban, Dania Movia, Catia Neto, Carla Owen, Lauri Paasonen, Kerri Anne Palmer, Geoffrey John Pilkington, Karen Pilkington, Adriele Prina-Mello, Clive Roper, Jonathan Sheard, Sheree Smith, Janette Ellen Turner, Ipsita Roy, Melissa Anne Tutty, Eirini Velliou, John Malcolm Wilkinson. Towards More Predictive, Physiological and Animal-free In Vitro Models: Advances in Cell and Tissue Culture 2020 Conference Proceedings. Alternatives to Laboratory Animals 2021; 49(3): 93 doi: 10.1177/02611929211025006
|
| 16 |
Yaqing Wang, Hui Wang, Pengwei Deng, Tingting Tao, Haitao Liu, Shuo Wu, Wenwen Chen, Jianhua Qin. Modeling Human Nonalcoholic Fatty Liver Disease (NAFLD) with an Organoids-on-a-Chip System. ACS Biomaterials Science & Engineering 2020; 6(10): 5734 doi: 10.1021/acsbiomaterials.0c00682
|
| 17 |
Ehsanollah Moradi, Sasan Jalili-Firoozinezhad, Mehran Solati-Hashjin. Microfluidic organ-on-a-chip models of human liver tissue. Acta Biomaterialia 2020; 116: 67 doi: 10.1016/j.actbio.2020.08.041
|
| 18 |
Albert Gough, Alejandro Soto-Gutierrez, Lawrence Vernetti, Mo R. Ebrahimkhani, Andrew M. Stern, D. Lansing Taylor. Human biomimetic liver microphysiology systems in drug development and precision medicine. Nature Reviews Gastroenterology & Hepatology 2021; 18(4): 252 doi: 10.1038/s41575-020-00386-1
|
| 19 |
Clare L. Thompson, Su Fu, Hannah K. Heywood, Martin M. Knight, Stephen D. Thorpe. Mechanical Stimulation: A Crucial Element of Organ-on-Chip Models. Frontiers in Bioengineering and Biotechnology 2020; 8 doi: 10.3389/fbioe.2020.602646
|
| 20 |
Kelsey Retting, Dwayne Carter, Candace Crogan-Grundy, Chirag Khatiwala, Leah Norona, Elizabeth Paffenroth, Umesh Hanumegowda, Alice Chen, Lisa Hazelwood, Lois Lehman-McKeeman, Sharon Presnell. Modeling Liver Biology and the Tissue Response to Injury in Bioprinted Human Liver Tissues. Applied In Vitro Toxicology 2018; 4(3): 288 doi: 10.1089/aivt.2018.0015
|
| 21 |
Tomasz Kostrzewski, Paloma Maraver, Larissa Ouro‐Gnao, Ana Levi, Sophie Snow, Alina Miedzik, Krista Rombouts, David Hughes. A Microphysiological System for Studying Nonalcoholic Steatohepatitis. Hepatology Communications 2020; 4(1): 77 doi: 10.1002/hep4.1450
|
| 22 |
Yimu Zhao, Erika Yan Wang, Fook B.L. Lai, Krisco Cheung, Milica Radisic. Organs-on-a-chip: a union of tissue engineering and microfabrication. Trends in Biotechnology 2023; 41(3): 410 doi: 10.1016/j.tibtech.2022.12.018
|
| 23 |
Veronica Zingales, Maria Rosaria Esposito, Noemi Torriero, Mercedes Taroncher, Elisa Cimetta, María-José Ruiz. The Growing Importance of Three-Dimensional Models and Microphysiological Systems in the Assessment of Mycotoxin Toxicity. Toxins 2023; 15(7): 422 doi: 10.3390/toxins15070422
|
| 24 |
Eric Wang, Melisa J. Andrade, Quinton Smith. Vascularized liver-on-a-chip model to investigate nicotine-induced dysfunction. Biomicrofluidics 2023; 17(6) doi: 10.1063/5.0172677
|
| 25 |
Joost Boeckmans, Alessandra Natale, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim M. Rodrigues. Human-based systems: Mechanistic NASH modelling just around the corner?. Pharmacological Research 2018; 134: 257 doi: 10.1016/j.phrs.2018.06.029
|
| 26 |
Seung Yeon Lee, Jong Hwan Sung. Gut–liver on a chip toward an in vitro model of hepatic steatosis. Biotechnology and Bioengineering 2018; 115(11): 2817 doi: 10.1002/bit.26793
|
| 27 |
Helle Sedighi Frandsen, Joel Mario Vej-Nielsen, Lauren Elizabeth Smith, Lang Sun, Karoline Lindgaard Mikkelsen, Annemette Præstegaard Thulesen, Christina Erika Hagensen, Fuquan Yang, Adelina Rogowska-Wrzesinska. Mapping Proteome and Lipidome Changes in Early-Onset Non-Alcoholic Fatty Liver Disease Using Hepatic 3D Spheroids. Cells 2022; 11(20): 3216 doi: 10.3390/cells11203216
|
| 28 |
Sophie Bauer, Charlotte Wennberg Huldt, Kajsa P. Kanebratt, Isabell Durieux, Daniela Gunne, Shalini Andersson, Lorna Ewart, William G. Haynes, Ilka Maschmeyer, Annika Winter, Carina Ämmälä, Uwe Marx, Tommy B. Andersson. Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14815-w
|
| 29 |
Tomasz Kostrzewski, Sophie Snow, Anya Lindström Battle, Samantha Peel, Zahida Ahmad, Jayati Basak, Manasa Surakala, Aurelie Bornot, Julia Lindgren, Maria Ryaboshapkina, Maryam Clausen, Daniel Lindén, Christian Maass, Lucy May Young, Adam Corrigan, Lorna Ewart, David Hughes. Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system. Communications Biology 2021; 4(1) doi: 10.1038/s42003-021-02616-x
|
| 30 |
Carlemi Calitz, Josias H. Hamman, Stephen J. Fey, Krzysztof Wrzesinski, Chrisna Gouws. Recent advances in three-dimensional cell culturing to assess liver function and dysfunction: from a drug biotransformation and toxicity perspective. Toxicology Mechanisms and Methods 2018; 28(5): 369 doi: 10.1080/15376516.2017.1422580
|
| 31 |
Ceri‐Anne E. Suurmond, Soufian Lasli, Floor W. van den Dolder, Aly Ung, Han‐Jun Kim, Praveen Bandaru, KangJu Lee, Hyun‐Jong Cho, Samad Ahadian, Nureddin Ashammakhi, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. In Vitro Human Liver Model of Nonalcoholic Steatohepatitis by Coculturing Hepatocytes, Endothelial Cells, and Kupffer Cells. Advanced Healthcare Materials 2019; 8(24) doi: 10.1002/adhm.201901379
|
| 32 |
Alex J. Wang, Allysa Allen, Marianna Sofman, Pierre Sphabmixay, Ece Yildiz, Linda G. Griffith. Engineering Modular 3D Liver Culture Microenvironments In Vitro to Parse the Interplay between Biophysical and Biochemical Microenvironment Cues on Hepatic Phenotypes. Advanced NanoBiomed Research 2022; 2(1) doi: 10.1002/anbr.202100049
|
| 33 |
Camilo Rey-Bedon, Peony Banik, Aslihan Gokaltun, O. Hofheinz, Martin.L. Yarmush, M. Korkut Uygun, O. Berk Usta. CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver. Biomedicine & Pharmacotherapy 2022; 146: 112377 doi: 10.1016/j.biopha.2021.112377
|
| 34 |
Alexandra Gatzios, Matthias Rombaut, Karolien Buyl, Joery De Kock, Robim M. Rodrigues, Vera Rogiers, Tamara Vanhaecke, Joost Boeckmans. From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights. Biomedicines 2022; 10(1): 161 doi: 10.3390/biomedicines10010161
|
| 35 |
Sayaka Deguchi, Kazuo Takayama. State-of-the-art liver disease research using liver-on-a-chip. Inflammation and Regeneration 2022; 42(1) doi: 10.1186/s41232-022-00248-0
|
| 36 |
Collin D. Edington, Wen Li Kelly Chen, Emily Geishecker, Timothy Kassis, Luis R. Soenksen, Brij M. Bhushan, Duncan Freake, Jared Kirschner, Christian Maass, Nikolaos Tsamandouras, Jorge Valdez, Christi D. Cook, Tom Parent, Stephen Snyder, Jiajie Yu, Emily Suter, Michael Shockley, Jason Velazquez, Jeremy J. Velazquez, Linda Stockdale, Julia P. Papps, Iris Lee, Nicholas Vann, Mario Gamboa, Matthew E. LaBarge, Zhe Zhong, Xin Wang, Laurie A. Boyer, Douglas A. Lauffenburger, Rebecca L. Carrier, Catherine Communal, Steven R. Tannenbaum, Cynthia L. Stokes, David J. Hughes, Gaurav Rohatgi, David L. Trumper, Murat Cirit, Linda G. Griffith. Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-22749-0
|
| 37 |
Vimal Veeriah, Seung-Hee Lee, Fred Levine. Long-term oral administration of an HNF4α agonist prevents weight gain and hepatic steatosis by promoting increased mitochondrial mass and function. Cell Death & Disease 2022; 13(1) doi: 10.1038/s41419-022-04521-5
|
| 38 |
Shuyun Rao, Xiaochun Yang, Kazufumi Ohshiro, Sobia Zaidi, Zhanhuai Wang, Kirti Shetty, Xiyan Xiang, Md. Imtaiyaz Hassan, Taj Mohammad, Patricia S. Latham, Bao-Ngoc Nguyen, Linda Wong, Herbert Yu, Yousef Al-Abed, Bibhuti Mishra, Michele Vacca, Gareth Guenigault, Michael E. D. Allison, Antonio Vidal-Puig, Jihane N. Benhammou, Marcus Alvarez, Päivi Pajukanta, Joseph R. Pisegna, Lopa Mishra. β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development. Science Translational Medicine 2021; 13(624) doi: 10.1126/scitranslmed.abk2267
|
| 39 |
Qianqian Xu. Human Three-Dimensional Hepatic Models: Cell Type Variety and Corresponding Applications. Frontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.730008
|
| 40 |
Shabir Hassan, Shikha Sebastian, Sushila Maharjan, Ami Lesha, Anne‐Marie Carpenter, Xiuli Liu, Xin Xie, Carol Livermore, Yu Shrike Zhang, Ali Zarrinpar. Liver‐on‐a‐Chip Models of Fatty Liver Disease. Hepatology 2020; 71(2): 733 doi: 10.1002/hep.31106
|
| 41 |
Engineered Liver-on-a-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review. Micromachines 2019; 10(10): 676 doi: 10.3390/mi10100676
|
| 42 |
Shengnan Ya, Weiping Ding, Shibo Li, Kun Du, Yuanyuan Zhang, Chengpan Li, Jing Liu, Fenfen Li, Ping Li, Tianzhi Luo, Liqun He, Ao Xu, Dayong Gao, Bensheng Qiu. On-Chip Construction of Liver Lobules with Self-Assembled Perfusable Hepatic Sinusoid Networks. ACS Applied Materials & Interfaces 2021; 13(28): 32640 doi: 10.1021/acsami.1c00794
|
| 43 |
Ajit Dash, William R. Proctor. Microfluidic Cell Culture Systems. 2019; : 159 doi: 10.1016/B978-0-12-813671-3.00006-2
|
| 44 |
Pierre Sphabmixay, Micha Sam Brickman Raredon, Alex J-S Wang, Howon Lee, Paula T Hammond, Nicholas X Fang, Linda G Griffith. High resolution stereolithography fabrication of perfusable scaffolds to enable long-term meso-scale hepatic culture for disease modeling. Biofabrication 2021; 13(4): 045024 doi: 10.1088/1758-5090/ac23aa
|
| 45 |
Kun Du, Shibo Li, Chengpan Li, Ping Li, Chunguang Miao, Tianzhi Luo, Bensheng Qiu, Weiping Ding. Modeling nonalcoholic fatty liver disease on a liver lobule chip with dual blood supply. Acta Biomaterialia 2021; 134: 228 doi: 10.1016/j.actbio.2021.07.013
|
| 46 |
Volker M. Lauschke, Reza Z. Shafagh, Delilah F. G. Hendriks, Magnus Ingelman‐Sundberg. 3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and Applications. Biotechnology Journal 2019; 14(7) doi: 10.1002/biot.201800347
|
| 47 |
Seung Yeon Lee, Donghyun Kim, Seung Hwan Lee, Jong Hwan Sung. Microtechnology-based in vitro models: Mimicking liver function and pathophysiology. APL Bioengineering 2021; 5(4) doi: 10.1063/5.0061896
|
| 48 |
Dennis McDuffie, David Barr, Madeline Helm, Thomas Baumert, Ashutosh Agarwal, Emmanuel Thomas. Physiomimetic In Vitro Human Models for Viral Infection in the Liver. Seminars in Liver Disease 2023; 43(01): 031 doi: 10.1055/a-1981-5944
|
| 49 |
Charlotte J. Green, Siôn A. Parry, Pippa J. Gunn, Carlo D.L. Ceresa, Fredrik Rosqvist, Marie-Eve Piché, Leanne Hodson. Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models. Hormone Molecular Biology and Clinical Investigation 2020; 41(1) doi: 10.1515/hmbci-2018-0038
|
| 50 |
Zahra Koohestani Sini, Mohammad Esmaeil Afzalpour, Mohsen Mohammadnia Ahmadi, Mohammad Ali Sardar, Sattar Gorgani Firuzjaee. The Effect of Aerobic Continuous Training on Myonectin, Insulin Resistance and Liver Enzymes in Rats with Nonalcoholic Fatty Liver Disease. Annals of Applied Sport Science 2020; 8(4): 0 doi: 10.29252/aassjournal.855
|
| 51 |
Kelly Tan, Philip Keegan, Miles Rogers, Mingjian Lu, James R. Gosset, Joe Charest, Shyam Sundhar Bale. A high-throughput microfluidic microphysiological system (PREDICT-96) to recapitulate hepatocyte function in dynamic, re-circulating flow conditions. Lab on a Chip 2019; 19(9): 1556 doi: 10.1039/C8LC01262H
|
| 52 |
Yao Teng, Zixuan Zhao, Farah Tasnim, Xiaozhong Huang, Hanry Yu. A scalable and sensitive steatosis chip with long-term perfusion of in situ differentiated HepaRG organoids. Biomaterials 2021; 275: 120904 doi: 10.1016/j.biomaterials.2021.120904
|
| 53 |
Jiu Deng, Xiuli Zhang, Zongzheng Chen, Yong Luo, Yao Lu, Tingjiao Liu, Zhengzhi Wu, Yu Jin, Weijie Zhao, Bingcheng Lin. A cell lines derived microfluidic liver model for investigation of hepatotoxicity induced by drug-drug interaction. Biomicrofluidics 2019; 13(2) doi: 10.1063/1.5070088
|
| 54 |
Rajagopal N. Aravalli, Clifford J. Steer. Utility of Common Marmoset (Callithrix jacchus) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism. Genes 2020; 11(7): 729 doi: 10.3390/genes11070729
|
| 55 |
Mikael Kozyra, Inger Johansson, Åsa Nordling, Shahid Ullah, Volker M. Lauschke, Magnus Ingelman-Sundberg. Human hepatic 3D spheroids as a model for steatosis and insulin resistance. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32722-6
|
| 56 |
Kirk P. Van Ness, Francine Cesar, Catherine K. Yeung, Jonathan Himmelfarb, Edward J. Kelly. Microphysiological systems in absorption, distribution, metabolism, and elimination sciences. Clinical and Translational Science 2022; 15(1): 9 doi: 10.1111/cts.13132
|
| 57 |
Simon Ströbel, Radina Kostadinova, Katia Fiaschetti-Egli, Jana Rupp, Manuela Bieri, Agnieszka Pawlowska, Donna Busler, Thomas Hofstetter, Katarzyna Sanchez, Sue Grepper, Eva Thoma. A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-01951-7
|
| 58 |
Charlotte J. Green, Thomas Marjot, Jeremy W. Tomlinson, Leanne Hodson. Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis?. Diabetes, Obesity and Metabolism 2019; 21(4): 749 doi: 10.1111/dom.13592
|
| 59 |
Chase P. Monckton, Salman R. Khetani. Drug-Induced Liver Toxicity. Methods in Pharmacology and Toxicology 2018; : 213 doi: 10.1007/978-1-4939-7677-5_11
|
| 60 |
Joong‐won Jeon, Seung Hwan Lee, Donghyun Kim, Jong Hwan Sung. In vitro hepatic steatosis model based on gut–liver‐on‐a‐chip. Biotechnology Progress 2021; 37(3) doi: 10.1002/btpr.3121
|
| 61 |
Chase P. Monckton, Grace E. Brown, Salman R. Khetani. Latest impact of engineered human liver platforms on drug development. APL Bioengineering 2021; 5(3) doi: 10.1063/5.0051765
|
| 62 |
Sonia Youhanna, Aurino M. Kemas, Lena Preiss, Yitian Zhou, Joanne X. Shen, Selgin D. Cakal, Francesco S. Paqualini, Sravan K. Goparaju, Reza Zandi Shafagh, Johan Ulrik Lind, Carl M. Sellgren, Volker M. Lauschke, Gunnar Schulte. Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives. Pharmacological Reviews 2022; 74(1): 141 doi: 10.1124/pharmrev.120.000238
|
| 63 |
Katharina S. Nitsche, Iris Müller, Sophie Malcomber, Paul L. Carmichael, Hans Bouwmeester. Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review. Archives of Toxicology 2022; 96(3): 711 doi: 10.1007/s00204-022-03234-0
|
| 64 |
Yasunori Tokuoka, Tadashi Ishida. Local Microbubble Removal in Polydimethylsiloxane Microchannel by Balancing Negative and Atmospheric Pressures. Micromachines 2023; 15(1): 37 doi: 10.3390/mi15010037
|
| 65 |
Milad Rezvani, Ludovic Vallier, Adrien Guillot. Modeling Nonalcoholic Fatty Liver Disease in the Dish Using Human-Specific Platforms: Strategies and Limitations. Cellular and Molecular Gastroenterology and Hepatology 2023; 15(5): 1135 doi: 10.1016/j.jcmgh.2023.01.014
|
| 66 |
Mohamed Albadry, Sebastian Höpfl, Nadia Ehteshamzad, Matthias König, Michael Böttcher, Jasna Neumann, Amelie Lupp, Olaf Dirsch, Nicole Radde, Bruno Christ, Madlen Christ, Lars Ole Schwen, Hendrik Laue, Robert Klopfleisch, Uta Dahmen. Periportal steatosis in mice affects distinct parameters of pericentral drug metabolism. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-26483-6
|
| 67 |
M. Yu. Shkurnikov, E. N. Knyazev, K. A. Fomicheva, M. S. Kasatkin, V. V. Arkov, Yu. A. Makarova. Detection of Low-Abundant MicroRNAs with Hybridization Microchips. Bulletin of Experimental Biology and Medicine 2019; 166(6): 788 doi: 10.1007/s10517-019-04441-z
|
| 68 |
Norman C. Peterson, Prathap Kumar Mahalingaiah, Aaron Fullerton, Matteo Di Piazza. Application of microphysiological systems in biopharmaceutical research and development. Lab on a Chip 2020; 20(4): 697 doi: 10.1039/C9LC00962K
|
| 69 |
Jana Hundertmark, Frank Tacke. How effective are nonalcoholic fatty liver disease models for drug discovery?. Expert Opinion on Drug Discovery 2020; 15(11): 1237 doi: 10.1080/17460441.2020.1776258
|
| 70 |
Tarun Agarwal, Aruja Rustagi, Joyjyoti Das, Tapas Kumar Maiti. PAMAM dendrimer grafted cellulose paper scaffolds as a novel in vitro 3D liver model for drug screening applications. Colloids and Surfaces B: Biointerfaces 2018; 172: 346 doi: 10.1016/j.colsurfb.2018.08.062
|
| 71 |
Victoria L. Slaughter, John W. Rumsey, Rachel Boone, Duaa Malik, Yunqing Cai, Narasimhan Narasimhan Sriram, Christopher J. Long, Christopher W. McAleer, Stephen Lambert, Michael L. Shuler, J. J. Hickman. Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92264-2
|
| 72 |
Gregory H. Underhill, Salman R. Khetani. Advances in Engineered Human Liver Platforms for Drug Metabolism Studies. Drug Metabolism and Disposition 2018; 46(11): 1626 doi: 10.1124/dmd.118.083295
|
| 73 |
Francesco De Chiara, Juan M. Fernández-Costa, Javier Ramón-Azcón, Justyna Grochala, Anna Paleczek, Dominik Grochala, Artur Rydosz. Human Organs-On-a-chip. 2024; : 187 doi: 10.1016/B978-0-443-15384-6.00007-0
|
| 74 |
Elisa Cauli, Michela Anna Polidoro, Simona Marzorati, Claudio Bernardi, Marco Rasponi, Ana Lleo. Cancer-on-chip: a 3D model for the study of the tumor microenvironment. Journal of Biological Engineering 2023; 17(1) doi: 10.1186/s13036-023-00372-6
|
| 75 |
Min Liu, Yuting Xiang, Yuqi Yang, Xingyu Long, Zuoxiu Xiao, Yayun Nan, Yitian Jiang, Yige Qiu, Qiong Huang, Kelong Ai. State-of-the-art advancements in Liver-on-a-chip (LOC): Integrated biosensors for LOC. Biosensors and Bioelectronics 2022; 218: 114758 doi: 10.1016/j.bios.2022.114758
|
| 76 |
A. M. Ortega-Prieto, J. K. Skelton, S. N. Wai, E. Large, M. Lussignol, G. Vizcay-Barrena, D. Hughes, R. A. Fleck, M. Thursz, M. T. Catanese, M. Dorner. 3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection. Nature Communications 2018; 9(1) doi: 10.1038/s41467-018-02969-8
|
| 77 |
Somnath Maji, Minkyoung Lee, Jooyoung Lee, Jaehee Lee, Hyungseok Lee. Development of lumen-based perfusable 3D liver in vitro model using single-step bioprinting with composite bioinks. Materials Today Bio 2023; 21: 100723 doi: 10.1016/j.mtbio.2023.100723
|
| 78 |
Peerut Chienwichai, Onrapak Reamtong, Usa Boonyuen, Trairak Pisitkun, Poorichaya Somparn, Prapin Tharnpoophasiam, Suwalee Worakhunpiset, Supachai Topanurak. Hepatic protein Carbonylation profiles induced by lipid accumulation and oxidative stress for investigating cellular response to non-alcoholic fatty liver disease in vitro. Proteome Science 2019; 17(1) doi: 10.1186/s12953-019-0149-9
|
| 79 |
Linjie Qiu, Bin Kong, Tiantian Kong, Huan Wang. Recent advances in liver‐on‐chips: Design, fabrication, and applications. Smart Medicine 2023; 2(1) doi: 10.1002/SMMD.20220010
|
| 80 |
Madeline Cooper, Joseph L. Charest, Jonathan Coppeta. Microfluidic Cell Culture Systems. 2019; : 1 doi: 10.1016/B978-0-12-813671-3.00001-3
|
| 81 |
Elise A. Aeby, Patrick M. Misun, Andreas Hierlemann, Olivier Frey. Microfluidic Hydrogel Hanging‐Drop Network for Long‐Term Culturing of 3D Microtissues and Simultaneous High‐Resolution Imaging. Advanced Biosystems 2018; 2(7) doi: 10.1002/adbi.201800054
|
| 82 |
María Virumbrales-Muñoz, José M. Ayuso, Max M. Gong, Mouhita Humayun, Megan K. Livingston, Karina M. Lugo-Cintrón, Patrick McMinn, Yasmín R. Álvarez-García, David J. Beebe. Microfluidic lumen-based systems for advancing tubular organ modeling. Chemical Society Reviews 2020; 49(17): 6402 doi: 10.1039/D0CS00705F
|
| 83 |
Murat Cirit, Cynthia L. Stokes. Maximizing the impact of microphysiological systems with in vitro–in vivo translation. Lab on a Chip 2018; 18(13): 1831 doi: 10.1039/C8LC00039E
|
| 84 |
Impreet Kaur, Ashwini Vasudevan, Preety Rawal, Dinesh M. Tripathi, Seeram Ramakrishna, Savneet Kaur, Shiv K. Sarin. Primary Hepatocyte Isolation and Cultures: Technical Aspects, Challenges and Advancements. Bioengineering 2023; 10(2): 131 doi: 10.3390/bioengineering10020131
|
| 85 |
David A. Kukla, Salman R. Khetani. Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine. Seminars in Liver Disease 2021; 41(03): 368 doi: 10.1055/s-0041-1731016
|
| 86 |
Ozlem Yesil‐Celiktas, Shabir Hassan, Amir K. Miri, Sushila Maharjan, Rawan Al‐kharboosh, Alfredo Quiñones‐Hinojosa, Yu Shrike Zhang. Mimicking Human Pathophysiology in Organ‐on‐Chip Devices. Advanced Biosystems 2018; 2(10) doi: 10.1002/adbi.201800109
|
| 87 |
Michela Anna Polidoro, Erika Ferrari, Simona Marzorati, Ana Lleo, Marco Rasponi. Experimental liver models: From cell culture techniques to microfluidic organs‐on‐chip. Liver International 2021; 41(8): 1744 doi: 10.1111/liv.14942
|
| 88 |
Pierre-Antoine Soret, Julie Magusto, Chantal Housset, Jérémie Gautheron. In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal. Journal of Clinical Medicine 2020; 10(1): 36 doi: 10.3390/jcm10010036
|
| 89 |
Gregory H. Underhill, Salman R. Khetani. Emerging trends in modeling human liver disease in vitro
. APL Bioengineering 2019; 3(4) doi: 10.1063/1.5119090
|
| 90 |
Fabrice A. Müller, Shana J. Sturla. Human in vitro models of nonalcoholic fatty liver disease. Current Opinion in Toxicology 2019; 16: 9 doi: 10.1016/j.cotox.2019.03.001
|
| 91 |
Pippa J. Gunn, Camilla Pramfalk, Val Millar, Thomas Cornfield, Matthew Hutchinson, Elspeth M. Johnson, Shilpa R. Nagarajan, Perla Troncoso‐Rey, Richard F. Mithen, Katherine E. Pinnick, Maria H. Traka, Charlotte J. Green, Leanne Hodson. Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis. Physiological Reports 2020; 8(13) doi: 10.14814/phy2.14482
|
| 92 |
Alfredo Smiriglia, Nicla Lorito, Marina Serra, Andrea Perra, Andrea Morandi, Marta Anna Kowalik. Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma. iScience 2023; 26(12): 108363 doi: 10.1016/j.isci.2023.108363
|
| 93 |
Soufian Lasli, Han‐Jun Kim, KangJu Lee, Ceri‐Anne E. Suurmond, Marcus Goudie, Praveen Bandaru, Wujin Sun, Shiming Zhang, Niyuan Zhang, Samad Ahadian, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. A Human Liver‐on‐a‐Chip Platform for Modeling Nonalcoholic Fatty Liver Disease. Advanced Biosystems 2019; 3(8) doi: 10.1002/adbi.201900104
|
| 94 |
Ujjal Sarkar, Kodihalli C. Ravindra, Emma Large, Carissa L. Young, Dinelia Rivera-Burgos, Jiajie Yu, Murat Cirit, David J. Hughes, John S. Wishnok, Douglas A. Lauffenburger, Linda G. Griffith, Steven R. Tannenbaum. Integrated Assessment of Diclofenac Biotransformation, Pharmacokinetics, and Omics-Based Toxicity in a Three-Dimensional Human Liver-Immunocompetent Coculture System. Drug Metabolism and Disposition 2017; 45(7): 855 doi: 10.1124/dmd.116.074005
|
| 95 |
Michele Vacca, Jack Leslie, Samuel Virtue, Brian Y. H. Lam, Olivier Govaere, Dina Tiniakos, Sophie Snow, Susan Davies, Kasparas Petkevicius, Zhen Tong, Vivian Peirce, Mette Juul Nielsen, Zsuzsanna Ament, Wei Li, Tomasz Kostrzewski, Diana Julie Leeming, Vlad Ratziu, Michael E. D. Allison, Quentin M. Anstee, Julian L. Griffin, Fiona Oakley, Antonio Vidal-Puig. Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis. Nature Metabolism 2020; 2(6): 514 doi: 10.1038/s42255-020-0214-9
|
| 96 |
Jiu Deng, Zongzheng Chen, Xiuli Zhang, Yong Luo, Zhengzhi Wu, Yao Lu, Tingjiao Liu, Weijie Zhao, Bingcheng Lin. A liver-chip-based alcoholic liver disease model featuring multi-non-parenchymal cells. Biomedical Microdevices 2019; 21(3) doi: 10.1007/s10544-019-0414-9
|
| 97 |
Cliff Rowe, Mohsen Shaeri, Emma Large, Terri Cornforth, Angela Robinson, Tomasz Kostrzewski, Rowena Sison-Young, Christopher Goldring, Kevin Park, David Hughes. Perfused human hepatocyte microtissues identify reactive metabolite-forming and mitochondria-perturbing hepatotoxins. Toxicology in Vitro 2018; 46: 29 doi: 10.1016/j.tiv.2017.09.012
|